Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

July 2027 107

  1. Study completion Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06987695

  2. Study completion Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07817251

  3. Study completion Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke Despite Oral Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06869811

  4. Primary completion Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06096246

  5. Primary completion CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06463561

  6. Primary completion Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06466161

  7. Primary completion Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06520774

  8. Primary completion Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07036965

  9. Study completion A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07619131

  10. Primary completion A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07619131

  11. Primary completion Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01187368

  12. Study completion Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05167786

  13. Primary completion Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05167786

  14. Primary completion Rehabilitation for Survivors of Out-of-hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05173740

  15. Study completion Cholesterol Lowering and Residual Risk in Diabetes, Type 1 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05641753

  16. Study completion Atherectomy Followed With a Drug Coated Balloon in the Treatment of Long Femoropopliteal Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05868564

  17. Primary completion Atherectomy Followed With a Drug Coated Balloon in the Treatment of Long Femoropopliteal Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05868564

  18. Study completion Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06369142

  19. Study completion A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06455098

  20. Primary completion A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06455098

  21. Primary completion Enhanced Community First Responder System Evaluation in Singapore Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06530433

  22. Study completion Efficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06743568

  23. Primary completion Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06775782

  24. Primary completion Effect of Dotinurad in Hyperuricemia With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06834230

  25. Primary completion PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06915792

  26. Primary completion Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07030621

  27. Study completion Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07067658

  28. Primary completion Electroacupuncture and rTMS for Post-Stroke Motor Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07113990

  29. Study completion Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07119021

  30. Primary completion A Multicenter Randomized Controlled Trial of Echocardiography-Guided Atrial Septal Defect Closure Performed in a Mobile Surgical Unit Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07273227

  31. Study completion A Usability Study of a Multi-channel ECG Monitoring Device Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07388355

  32. Primary completion A Usability Study of a Multi-channel ECG Monitoring Device Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07388355

  33. Study completion CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07465549

  34. Primary completion AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07491029

  35. Primary completion A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07521007

  36. Study completion A Post-Marketing Clinical Trial of Pemafibrate in Patients with Hypercholesterolemia and Inadequate Response to Statins Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07634484

  37. Primary completion A Post-Marketing Clinical Trial of Pemafibrate in Patients with Hypercholesterolemia and Inadequate Response to Statins Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07634484

  38. Study completion A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07654140

  39. Study completion Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07697833

  40. Study completion Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07837934

  41. Primary completion Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07837934

  42. Study completion Efficacy and Safety of High-Flow Nasal Cannula During Transcatheter Closure Procedures Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07937579

  43. Primary completion Efficacy and Safety of High-Flow Nasal Cannula During Transcatheter Closure Procedures Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07937579

  44. Primary completion Swiss Pilot Screening Study for Unruptured Intracranial Aneurysms to Prevent Subarachnoid Hemorrhage in Smokers Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07938775

August 2027 82

  1. Primary completion Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05491200

  2. Study start Conscious Sedation Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06049615

  3. Study completion Permanent Intracranial Stenting for Acute Ischemic Stroke Related to a Refractory Large Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06071091

  4. Study completion Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06281977

  5. Study completion SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06373601

  6. Primary completion SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06373601

  7. Study completion The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06427343

  8. Primary completion The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06427343

  9. Primary completion Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07073469

  10. Study completion Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion - The DCB-CTO Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07369765

  11. Study completion Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07706075

  12. Primary completion Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07776054

  13. Primary completion The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs). Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02998229

  14. Study completion Ventripoint Single Ventricle Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05262907

  15. Primary completion Ventripoint Single Ventricle Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05262907

  16. Study completion Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05918861

  17. Primary completion Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05918861

  18. Study completion Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06027307

  19. Primary completion Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06516653

  20. Study completion Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06784466

  21. Study completion A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06972472

  22. Primary completion A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06972472

  23. Study completion A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06993792

  24. Primary completion A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06993792

  25. Study completion AI-Assisted Interpretation of Cardiac CT in the Emergency Department Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07235657

  26. Study completion Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07282743

  27. Primary completion Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07308184

  28. Study completion Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07365358

  29. Primary completion Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07365358

  30. Primary completion Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07376447

  31. Study completion triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07440381

  32. Primary completion triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07440381

  33. Primary completion Photobiomodulation in Coronary Artery Bypass Grafting With No-Touch vs Conventional Saphenous Vein Harvesting. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07699679

  34. Primary completion Bachmann's Bundle Versus Right Atrial Appendage Pacing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07874763

  35. Study completion Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07898709

  36. Study completion Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05591118

  37. Study completion IVUS Guided PCI in Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06813534

  38. Primary completion A Study of Zigakibart in Adults With IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05852938

  39. Study completion Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07588438

  40. Primary completion Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07588438

  41. Study completion Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07000045

  42. Study completion A Randomized Clinical Trial on Urgent Angioplasty for IntraCranial Atherosclerotic Stenosis-related Large-Vessel Occlusion After Mechanical Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06702657

  43. Primary completion Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07670065

  44. Study completion Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07830719

  45. Primary completion Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07830719

  46. Primary completion To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07098195

  47. Primary completion Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07449910

  48. Primary completion Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07586865

  49. Primary completion Left Bundle Branch Area Pacing Versus Right Ventricular Pacing in Atrioventricular Block With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07464041

  50. Study completion Argus 2.0 Adoption Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07425236

  51. Primary completion Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06586203

  52. Primary completion Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06059144

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation Registry record

    Expected 2019-12-15; that period ended on 2019-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03367325

  2. Primary completion Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation Registry record

    Expected 2019-12-15; that period ended on 2019-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03367325

  3. Study completion Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity Registry record

    Expected 2019-12-18; that period ended on 2019-12-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03042741

  4. Primary completion Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity Registry record

    Expected 2019-12-18; that period ended on 2019-12-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03042741

  5. Study completion A Randomized Controlled Trial Evaluating One Drop | Premium With Afrezza vs. One Drop | Premium Alone Registry record

    Expected 2019-12-30; that period ended on 2019-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03313960

  6. Primary completion Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent Registry record

    Expected 2019-12-30; that period ended on 2019-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03318796

  7. Primary completion Effectiveness of the Application(APP) on Individualized Antithrombotic Therapy Registry record

    Expected 2019-12-30; that period ended on 2019-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03454854

  8. Study completion Fixed-Free HTN Trial Registry record

    Expected 2019-12-30; that period ended on 2019-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03578042

  9. Study completion Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke. Registry record

    Expected 2019-12-30; that period ended on 2019-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03733002

  10. Primary completion Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke. Registry record

    Expected 2019-12-30; that period ended on 2019-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03733002

  11. Primary completion A Prospective Randomized Multicenter Trial of the Guidewire for Echo-guided Interventions Registry record

    Expected 2019-12-30; that period ended on 2019-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04096924

  12. Study completion Recurrent Stroke Prevention Clinical Outcome Study Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01198496

  13. Primary completion Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01313533

  14. Primary completion PV Reconnection After PVAI at Different Power Settings and Adenosine Provocation Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01672346

  15. Primary completion THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS) Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02002325

  16. Study completion Eplerenone in the Management of Abdominal Aortic Aneurysms Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02345590

  17. Study completion A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02371512

  18. Primary completion A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02371512

  19. Study completion Effect of Ambulatory BP Monitoring on the CliniCal coUrse and RenAl ouTcomE of CKD Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02417571

  20. Primary completion Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02517827

  21. Study completion Subclinical Postoperative Atrial Fibrillation Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02522364

  22. Study completion GutHeart: Targeting Gut Microbiota to Treat Heart Failure Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02637167

  23. Primary completion Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN) Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02639793

  24. Study completion Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02641821

  25. Primary completion Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02641821

  26. Study completion Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure Management Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02673073

  27. Study completion Consolidating Tools for Outcomes in Resuscitation Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02676024

  28. Study completion Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS) Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02728180

  29. Primary completion Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS) Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02728180

  30. Primary completion Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE) Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02762851

  31. Primary completion Clinical Study of Stent Versus Direct Atherectomy Versus Angioplasty to Treat Lower Limb In-stent Restenosis Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02832024

  32. Study completion Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02859480

  33. Study completion A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome) Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02875639

  34. Primary completion A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome) Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02875639

  35. Primary completion In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02892903

  36. Study completion The Response To Ajmaline Provocation in Healthy Subjects Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02933437

  37. Primary completion The Response To Ajmaline Provocation in Healthy Subjects Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02933437

  38. Study completion Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02946632

  39. Primary completion Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02946632

  40. Study completion A RCT on Supraglottic Airway Versus Endotracheal Intubation in OHCA Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02967952

  41. Primary completion PCSK9 Inhibitors in the Progression of Aortic Stenosis Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03051360

  42. Primary completion Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03098732

  43. Study completion Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina. Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03171597

  44. Study completion Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina. Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03179514

  45. Study completion Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina. Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03179527

  46. Study completion Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina. Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03179618

  47. Primary completion Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01) Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03195023

  48. Primary completion Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03279484

  49. Study completion A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03320031

  50. Primary completion A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03320031

  51. Study completion Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03340090

  52. Primary completion Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03340090

  53. Study completion Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03437226

  54. Study completion Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03513029

  55. Primary completion Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03513029

  56. Primary completion Dabigatran Versus Warfarin With NVAF Who Undergo PCI Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03536611

  57. Study completion Clinical Trial on Remote Ischemic Conditioning and Hypertension(HOPE) Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03566654

  58. Primary completion Clinical Trial on Remote Ischemic Conditioning and Hypertension(HOPE) Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03566654

  59. Primary completion Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03587558

  60. Primary completion Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03592823

  61. Primary completion Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03605433

  62. Study completion Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03666806

  63. Study completion Primary Technology Enhanced Care in Hypertension Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03698890

  64. Primary completion Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03700645

  65. Study completion Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03755700

  66. Primary completion Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03755700

  67. Study completion Individualized rTMS Protocol for Stroke Recovery Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03828435

  68. Primary completion Individualized rTMS Protocol for Stroke Recovery Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03828435

  69. Study completion Effect of Rotating Magnetic Therapy on Blood Glucose Spectrum of Type 2 Diabetic Patients With Glargine Therapy Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03983187

  70. Study start PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI Registry record

    Expected 2019-12; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04045873

  71. Primary completion Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus Registry record

    Expected 2019-12-31; that period ended on 2019-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04120623

  72. Study completion PCSK9 Inhibitors in the Progression of Aortic Stenosis Registry record

    Expected 2020-01-01; that period ended on 2020-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03051360

  73. Study start Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. Registry record

    Expected 2020-01-01; that period ended on 2020-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03454724

  74. Primary completion Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion Registry record

    Expected 2020-01-01; that period ended on 2020-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04091412

  75. Primary completion Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation Registry record

    Expected 2020-01-01; that period ended on 2020-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04209959

  76. Study completion COmprehensive Remote Ischemic Conditioning in Myocardial Infarction Registry record

    Expected 2020-01-30; that period ended on 2020-01-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03233919

  77. Study completion Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection. Registry record

    Expected 2020-01-30; that period ended on 2020-01-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03855826

  78. Primary completion Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection. Registry record

    Expected 2020-01-30; that period ended on 2020-01-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03855826

  79. Study completion Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics Registry record

    Expected 2020-01; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01001962

  80. Study completion Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent Registry record

    Expected 2020-01; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01939249

  81. Study completion Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN) Registry record

    Expected 2020-01; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02639793

  82. Study completion Study of Safety and Efficacy of a Left Atrial Appendage Occulder Registry record

    Expected 2020-01; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02937025

  83. Study start Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction Registry record

    Expected 2020-01; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03041259

  84. Primary completion A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure Registry record

    Expected 2020-01; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03082508

  85. Study completion Optimized Remote Ischemic Conditioning (RIC) Treatment for Patients With Chronic Cerebral Ischemia Registry record

    Expected 2020-01; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03105141

  86. Study completion Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease Registry record

    Expected 2020-01-31; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03700645

  87. Primary completion A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy Registry record

    Expected 2020-01-31; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03834207

  88. Primary completion Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy Registry record

    Expected 2020-01-31; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03874260

  89. Study start NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events Registry record

    Expected 2020-01; that period ended on 2020-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04205578

  90. Primary completion Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety Registry record

    Expected 2020-02-01; that period ended on 2020-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03667677

  91. Study start Progesterone in the Treatment of Acute Hemorrhagic Stroke Registry record

    Expected 2020-02-01; that period ended on 2020-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04143880

  92. Study completion Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation Registry record

    Expected 2020-02-01; that period ended on 2020-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04209959

  93. Primary completion Impact of Self-monitoring of Salt Intake by Salt Meter in Hypertensive Patients Registry record

    Expected 2020-02-21; that period ended on 2020-02-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04286802

  94. Study completion Efficacy and Safety of Balloon Guide Catheter in Mechanical Thrombectomy Patients Registry record

    Expected 2020-02-28; that period ended on 2020-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03754738

  95. Primary completion Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery Registry record

    Expected 2020-02-28; that period ended on 2020-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03838328

  96. Study completion Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes Registry record

    Expected 2020-02-28; that period ended on 2020-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03917784

  97. Study completion Stroke Home Rehabilitation With WeReha Registry record

    Expected 2020-02-28; that period ended on 2020-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03964662

  98. Primary completion Stroke Home Rehabilitation With WeReha Registry record

    Expected 2020-02-28; that period ended on 2020-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03964662

  99. Study completion Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus Registry record

    Expected 2020-02-28; that period ended on 2020-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04120623

  100. Study completion Impact of Self-monitoring of Salt Intake by Salt Meter in Hypertensive Patients Registry record

    Expected 2020-02-28; that period ended on 2020-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04286802